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Kristian F. Axelsson 
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, 
Sahlgrenska Academy, University of Gothenburg, Sweden, 2020. 
Abstract 
In an ageing population, osteoporotic fractures become more common and cause 
increased morbidity, mortality and societal cost. This thesis aimed to determine the 
potential role of fracture liaison services (FLS) and alendronate treatment on fracture 
risk in those with a recent fracture, in the elderly and in those treated with oral 
prednisolone. 
All four papers in this thesis are retrospective cohort studies. In the first two papers, we 
used regional electronic health records to study patients 50 years or older with a recent 
major osteoporotic fracture. Patients in FLS hospitals were compared to historic controls 
or patients at non-FLS hospitals. The chance of receiving examination with dual-energy 
X-ray absorptiometry (DXA) and osteoporosis medication was investigated as well as 
the risk of sustaining a recurrent fracture. In the last two papers, we used national 
registers to study the risk of fracture after alendronate treatment in elderly and 
prednisolone users respectively versus propensity score matched controls without 
alendronate treatment. 
Implementation of FLS was associated with an 18% reduced risk of recurrent fracture. 
Also, implementation of a minimal resource FLS increased the proportion of patients 
being investigated with DXA and the chance to receive osteoporosis medication after 
fracture reached levels comparable to FLS types using conventional coordinator-based 
models. Alendronate prescribed to older patients (≥80 years) with prior fracture was 
associated with reduced risk of hip fracture by 38% with sustained safety. Alendronate 
prescribed to patients 65 years or older treated with oral prednisolone was associated 
with a 65% reduction in hip fracture risk. 
Preventive efforts such as FLSs and alendronate treatment in elderly and prednisolone 
users are associated with reduced risk of fracture. An increased use of FLSs and 
alendronate treatment would reduce fracture incidence, thereby mitigating suffering and 
costs resulting from fractures. 
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